Patanjali Ayurved, known for its herbal FMCG products, has received final regulatory clearance from the Insurance Regulatory and Development Authority of India (IRDAI) to enter the insurance sector via a nearly Rs 4,500 crore acquisition of Magma General Insurance, according to a report by The Economic Times cited by Business Today. The approval, received on July 28, was the last key milestone for the transaction announced in March.
Deal Structure and Ownership
Under the approved terms, Patanjali Ayurved will acquire a 73.6% stake in Magma General Insurance. The Dharampal Satyapal Group (DS Group), known for its Rajnigandha pan masala brand, will acquire a 24.5% stake as a co-investor, the report stated. The stakes are being acquired from Adar Poonawalla-owned Sanoti Properties and other selling shareholders, including Celica Developers and Jaguar Advisory Services. Sanoti held 72.4% in Magma before the transaction. As part of the IRDAI approval, Patanjali will become the insurer's promoter and will continue to infuse capital to support solvency and growth.
Magma General Insurance: Financial Performance
Magma's financial performance shows strong growth and recent profitability. The insurer's gross direct premium grew at a compound annual rate of 22% between FY21 and FY25, reaching Rs 3,334 crore, according to CareEdge Ratings data cited by ET. This compares to the general insurance industry's 10% CAGR over the same period.
| Metric | Value |
|---|---|
| Gross direct premium (FY25) | Rs 3,334 crore |
| Premium CAGR (FY21-FY25) | 22% |
| Industry premium CAGR (FY21-FY25) | 10% |
| Profit/(loss) FY25 | Profit Rs 1 crore |
| Profit/(loss) FY24 | Loss Rs 141 crore |
| Net profit first 9 months FY26 | Rs 27 crore |
| Solvency margin (Dec 31, 2025) | 1.81 times (threshold 1.50) |
| Excess capital over regulatory requirement | Rs 268 crore |
Magma reached breakeven in FY25, reporting a profit of Rs 1 crore against a loss of Rs 141 crore in FY24. In the first nine months of FY26, it posted a net profit of Rs 27 crore. Its solvency margin stood at 1.81 times on December 31, 2025, above the regulatory threshold of 1.50 times, translating into excess capital of Rs 268 crore.
Regulatory and Strategic Implications
For finance executives tracking diversification into financial services, this entry by a large FMCG player into insurance highlights the growing appeal of the Indian insurance sector, driven by low penetration and regulatory support. The IRDAI approval process, which required Patanjali to commit to ongoing capital infusion, reflects the regulator's focus on maintaining solvency and policyholder protection. The acquisition structure — Patanjali as promoter and DS Group as co-investor — spreads the capital commitment while leveraging each group's distribution strengths. The Rs 4,500 crore deal value underscores the capital requirement for entering the general insurance space, a sector that has seen premium growth outpacing the broader industry. The target company's improved profitability and strong solvency position provide a solid foundation for the new owners.
Sources:
